Print page Resize text Change font-size Change font-size Change font-size

WP7: Training and communication

The general objective of WP7 is to identify training opportunities and support training programmes in the field addressed by PROTECT.

Specific objectives are to:

  • Identify training programme deliverables from this research project that would lend themselves to undergraduate and continuous education, and liaise with the IMI pharmacovigilance Training Consortium;
  • Identify best tools for disseminating project results and increasing expertise outside the consortium within PROTECT, pharmaceutical companies and other interested stakeholders;
  • Promote uptake of methodologies by interested stakeholders;
  • Identify training opportunities from within the consortium that may be offered to consortium partners (e.g. by exchange of expertise) and to students involved in the PhD programme on benefit-risk communication organised by the IMI pharmacovigilance Training Consortium.


Related Information:


Partners involved:


+ GlaxoSmithKline Research and Development LTD (GSK)


+ International Alliance of Patients' Organizations (IAPO)


+ Fundació Institut Català de Farmacologia (FICF)


+ Stiftelsen WHO Collaborating Centre for International Drug Monitoring (UMC)


+ Novartis Pharma AG (Novartis)